COLBY GALLAGHER: Open Payments
NPI 1609359504 · NORTHAMPTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 7 payments from 5 companies in 2025. Trend: 2023 $690 · 2024 $798 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $319 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $139 |
| KYOWA KIRIN, INC. | 1 | $113 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $105 |
Products named: Wegovy, REZDIFFRA, INGREZZA, CRYSVITA, Ozempic, NEFFY.
Industry payments across MA — which companies pay providers there.
